Autolus For Profit
.jpg)
Prana Biotechnology has developed a proprietary library of class-leading chemical compounds.
Technology:
Other
Industry:
Regenerative medicine
Headquarters:
Others
Investors Number:
4
Total Funding:
â¬25M
Estimated Revenue:
$50M to $100M
Last Funding Type:
Series A
Register and Claim Ownership